Oppenheimer made a significant adjustment to Zentalis Pharmaceuticals' (NASDAQ:ZNTL) price target, reducing it from $20.00 to ...

As per the recent earnings update by FactSet dated 24th January 2025, the Q4 2024 earnings season for the S&P 500 has seen a ...

Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...

Needham analysts increased their price target on Merit Medical Systems , Inc. (NASDAQ: NASDAQ:MMSI) shares from $109.00 to ...

Adial Pharmaceuticals announced completion of PK study for AD04, confirming predictable bioavailability, dose proportionality ...

PMGC Holdings Inc. (NASDAQ:ELAB), a pharmaceutical preparations company, announced on Monday that it has successfully completed transactions under a warrant inducement agreement, resulting in gross ...

Ascendis Pharma boasts several commercial stage products. Read why ASND stock is an interesting speculative investment ...

Alnylam Pharmaceuticals , Inc. (NASDAQ:ALNY), a leader in RNA interference (RNAi) therapeutics, stands at a pivotal juncture as it seeks to capitalize on the burgeoning market for ...

XOMA Royalty Corp (NASDAQ:XOMA), a $313 million market cap company, experienced a significant stock sale as reported in a recent SEC filing. Several major investors, including BVF Partners L.P., ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock ...